Editor(s):

(1) Dr. Manabu Makinodan, Nara Medical University, Japan.

(2) Prof. (Dr.) Kashmira J. Gohil, Director/Dean, Anand College of Pharmacy, Sharda Group of Institutions (SGI), Agra, India.

(3) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.

Reviewers:

(1) Lennart Hardell, Örebro University Hospital, Sweden.

(2) P. Suresh, Pondicherry University, India.

Additional Reviewers:

 

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

---

Stage 1 | Original Manuscript | File 1 | NA

---

Stage 2 | Peer review report_1 (Lennart Hardell, Sweden) | File 1 | NA

---

Stage 2 | Peer review report_2 (P. Suresh, India) | File 1 | NA

---

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

---

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

---

Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA

---

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

---

Stage 3 | Comment_Editor_3_v1 | File 1 | NA

---